NOVELION THERAPEUTICS INC. (NVLNF) [Rocket]

In millions, except per share items	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13	Dec-31-12	Dec-31-11
	10-K	10-K	10-K	10-K	10-K	10-K	10-K	10-K
Assets
Cash and equivalents	45.2	55.4	108.9	141.8	155.9	118.5	307.4	205.6
Accounts receivable, net	28.9	22.2	9.3	0.3	0.4	4.6	4.0	10.0
Inventories	12.7	15.9	15.7
Other current assets	15.7	11.4	32.2	0.6	1.1	38.7	51.7	58.1
Total current assets	102.5	104.9	166.1	142.7	157.4	161.8	363.0	273.7
Property, plant, and equipment, net	1.6	2.9	4.2	0.4	1.0	1.9	2.7	3.3
Intangibles	200.2	225.3	250.3
Other fixed assets	1.2	2.2	1.2					0.9
Total assets	341.7	369.3	480.8	145.2	160.4	163.9	401.2	344.5

Accounts payable	6.0	13.8	17.6	1.7	1.9	2.6	6.1	6.1
Accrued expenses	44.2	41.8	37.2	1.8	1.5	1.5	2.5	7.7
Short-term and curr portion of long-term debt [+]	348.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Short-term debt	73.7
Current portion of long-term debt	274.8
Deferred revenues							0.5
Other current liabilities	11.7	8.6	64.0			0.1	1.9	0.0
Total current liabilities	410.4	64.2	118.8	3.5	3.5	4.2	11.0	13.8
Long-term debt		258.5	225.6
Other liabilities	20.2	31.6	0.6	0.3	0.4	1.8	1.9	1.7
Total liabilities	430.6	354.4	345.0	3.8	3.9	6.1	12.9	15.5

Shareholders' equity [+]	-88.9	14.9	135.8	141.3	156.5	157.8	388.3	329.0
Paid-in capital	79.3	73.2	69.1	97.4	97.8	95.8	296.0	296.0
Retained earnings	-822.3	-714.0	-587.2	-534.3	-511.3	-507.3	-482.4	-528.1
Tangible shareholders' equity	-289.0	-210.3	-114.5	141.3	156.5	157.8	388.3	329.0